Literature DB >> 8339907

Purification of the Neisseria meningitidis transferrin binding protein-2 (TBP2) to homogeneity using column chromatography.

L Ferrón1, C M Ferreirós, M T Criado, M P Andrade.   

Abstract

A method for purifying TBP2 from N. meningitidis has been developed using affinity chromatography on Tf-agarose followed by ion exchange chromatography; the Tf-binding activity of fractions was evaluated by a dot-blot technique. This method allowed the purification of the TBP2 in milder conditions than those used previously and to a high degree of homogeneity as was demonstrated by Coomassie brilliant blue or Silver staining after SDS-PAGE electrophoresis. The SDS-PAGE profile of the material obtained in the Tf-agarose affinity chromatography step shows only two detectable proteins, identified as the TBP1 and the TBP2, with a small amount of contamination. Passage through a MonoQ HR anion exchange column, allowed the isolation of TBP2 in the absence of TBP1. Our results demonstrate the conservation of the antigenic reactivity of this protein, which produces monospecific serum with the antibodies elicited reacting exclusively with the TBP2 in whole outer membrane vesicles.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8339907     DOI: 10.1111/j.1574-6968.1993.tb06161.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  5 in total

1.  Expression and purification of functional recombinant meningococcal transferrin-binding protein A.

Authors:  Jonathan S Oakhill; Christopher L Joannou; Susan K Buchanan; Andrew R Gorringe; Robert W Evans
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

2.  Immunization with recombinant transferrin binding protein B enhances clearance of nontypeable Haemophilus influenzae from the rat lung.

Authors:  D C Webb; A W Cripps
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection.

Authors:  D West; K Reddin; M Matheson; R Heath; S Funnell; M Hudson; A Robinson; A Gorringe
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

4.  Binding and utilization of human transferrin by Prevotella nigrescens.

Authors:  P Duchesne; D Grenier; D Mayrand
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

5.  Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines.

Authors:  L Lissolo; G Maitre-Wilmotte; P Dumas; M Mignon; B Danve; M J Quentin-Millet
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.